Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
8,71 USD | +1,04% | +0,23% | +8,60% |
23/04 | Bausch Health in 'posizione più forte' per la distribuzione di Bausch + Lomb, dice RBC | MT |
23/04 | RBC prevede il Q1 di Bausch Health, riducendo l'obiettivo a 11 dollari. | MT |
Attività
Numero di dipendenti: 20 270
Vendite per attività
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Bausch + Lomb/International
47,3
%
| 4 905 | 46,4 % | 5 596 | 47,3 % | +14,07% |
Salix
25,7
%
| 2 721 | 25,7 % | 3 037 | 25,7 % | +11,61% |
International
12,2
%
| 1 286 | 12,2 % | 1 446 | 12,2 % | +12,38% |
Diversified
10,8
%
| 1 273 | 12,0 % | 1 273 | 10,8 % | -0,04% |
Solta Medical
4,0
%
| 391 | 3,7 % | 468 | 4,0 % | +19,92% |
Vendite per regione
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Puerto Rico
59,3
%
| 6 296 | 59,5 % | 7 010 | 59,3 % | +11,35% |
Other
11,5
%
| 1 155 | 10,9 % | 1 365 | 11,5 % | +18,17% |
China
5,0
%
| 538 | 5,1 % | 595 | 5,0 % | +10,70% |
Canada
4,2
%
| 457 | 4,3 % | 494 | 4,2 % | +8,10% |
Mexico
3,7
%
| 359 | 3,4 % | 435 | 3,7 % | +20,95% |
Poland
3,6
%
| 362 | 3,4 % | 431 | 3,6 % | +18,96% |
France
2,4
%
| 264 | 2,5 % | 289 | 2,4 % | +9,29% |
Japan
2,2
%
| 260 | 2,5 % | 262 | 2,2 % | +0,56% |
Germany
1,7
%
| 191 | 1,8 % | 205 | 1,7 % | +7,20% |
Russia
1,7
%
| 236 | 2,2 % | 200 | 1,7 % | -15,23% |
United Kingdom
1,4
%
| 150 | 1,4 % | 169 | 1,4 % | +12,69% |
South Korea
1,1
%
| 100 | 0,9 % | 126 | 1,1 % | +25,22% |
Spain
1,1
%
| 109 | 1,0 % | 124 | 1,1 % | +13,55% |
Italy
1,0
%
| 99 | 0,9 % | 116 | 1,0 % | +17,32% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/05/22 |
Chief Operating Officer | - | - | |
Tage Ramakrishna
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/11 |
Investor Relations Contact | - | 19/06/17 | |
Human Resources Officer | - | 01/01/19 | |
Jeff Hartness
LAW | General Counsel | - | - |
Dennis Asharin
PRN | Corporate Officer/Principal | - | 01/01/07 |
Treasurer | 48 | - | |
Corporate Officer/Principal | 59 | 08/08/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/08 |
John Paulson
CHM | Chairman | 68 | 01/06/17 |
Steven Miller
BRD | Director/Board Member | 35 | 17/03/21 |
Richard Mulligan
BRD | Director/Board Member | 69 | 06/05/22 |
Brett Icahn
BRD | Director/Board Member | 44 | 17/03/21 |
Russel Robertson
BRD | Director/Board Member | 76 | 14/06/16 |
Thomas Ross
BRD | Director/Board Member | 73 | 08/03/16 |
Sarah Kavanagh
BRD | Director/Board Member | 67 | 22/07/16 |
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
Amy Wechsler
BRD | Director/Board Member | 54 | 14/06/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 366 672 723 | 358 095 255 ( 97,66 %) | 0 | 97,66 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
BAUSCH + LOMB CORPORATION 88.45% | 310 449 643 | 88.45% | 5 370 778 824 $ |
Coordinate società
Bausch Health Cos., Inc.
2150 St. Elzéar Boulevard West
H7L 4A8, Laval
+514 744 6792
http://www.bauschhealth.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Bausch & Lomb India Pvt Ltd.
Bausch & Lomb India Pvt Ltd. Electronic ComponentsElectronic Technology Part of Bausch Health Cos., Inc., Bausch & Lomb India Pvt Ltd. is a private company that specializes in providing soft contact lenses and lens care products. The company was founded in 2000. The company is based in Gurgaon, India. The Indian company's main focus is to help people see better and live better by providing soft contact lenses that are specifically shaped to focus light into the retina of the eye. Additionally, Bausch + Lomb offers a complete line of soft contact lens care products designed to make the lens wearing experience healthy and comfortable. |
Electronic Components
|
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+8,60% | 3,19 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione BHC
- Società Bausch Health Companies Inc.